Cybin (HELP) EBIT (2020 - 2022)

Cybin's (HELP) quarterly EBIT came in at $4.6 million in Q2 2022, up 3025.44% on a QoQ basis from $145656.7 in Q1 2021.

Cybin (HELP) EBIT (2020 - 2022) Analysis & Trends

Cybin (HELP) has 3 years of EBIT data on file, last reported at $4.6 million in Q2 2022.

Quarterly EBIT changed N/A year-over-year to $4.6 million in Q2 2022, while the trailing twelve-month figure through May 2022 was -$157.4 million (changed N/A YoY) and the FY2026 annual result came in at -$79.6 million, down 49.0% from the prior year.
EBIT grew to $4.6 million in Q2 2022, from $145656.7 in the prior quarter.
In the past five years, EBIT ranged from a high of $144.2 million in Q2 2020 to a low of -$162.1 million in Q4 2020.
A 3-year average of -$2.6 million and a median of $145656.7 in 2021 frame the typical range for EBIT.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.29 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	493.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-505.13 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	325.05 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-3,158.03
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	133.12 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	231.44 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-1.55 Mn
10	Cybin	417.29 Mn	417.29 Mn	-	-

Download Data